• Successful U.S. PoC with Sony underscores accelerated global market expansion
• Joint showcases with Korea Pavilion, hosted by MOLIT•LG CNS highlight Korea’s leadership and the global competitiveness of ITS technology

SEOUL, South Korea, Aug. 29, 2025 /PRNewswire/ — Nota AI (CEO Myungsu Chae), a company specializing in AI model compression and optimization, announced the successful conclusion of its participation at the ITS World Congress 2025 (ITSWC 2025), held in Atlanta, Georgia, from August 24 to 28.  Recognized as the world’s largest event dedicated to Intelligent Transport Systems (ITS), the Congress brought together more than 15,000 attendees and 200 companies from around the globe.

At this exhibition, Nota AI operated joint booths at the Korea Pavilion, hosted by the Ministry of Land, Infrastructure and Transport (MOLIT) and the LG CNS booth, while also showcasing the results of its collaboration with Sony. The company focused on highlighting the global competitiveness of its generative AI-based ITS technologies, powered by its proprietary Vision-Language Model (VLM).

At the Korea Pavilion, hosted by MOLIT, Nota AI showcased its generative AI-based intelligent incident detection system. Developed independently by Nota AI, this technology uses a VLM to detect various hazardous situations such as traffic accidents, fires, and road obstacles in real time. Additionally, it analyzes the correlation between events to minimize unnecessary alarms during incident detection, making it a next-generation control technology that captures the attention of visitors.

In the LG CNS booth, Nota AI presented its AI-powered intelligent traffic management solutions, which received significant attention from international visitors. The solution analyzes the movement of key objects such as vehicles and pedestrians on roads and in ports, quickly sending alerts during emergencies. The system also enhances operational efficiency and safety and facilitates real-time communication with various agents through V2X communication.

Additionally, Nota AI showcased its excellent technical capabilities by revealing the successful PoC results conducted in Lakewood, U.S., in collaboration with Sony. The project focused on verifying the potential for pedestrian safety management and traffic volume analysis in a specific area known for frequent jaywalking accidents. Nota AI’s proprietary AI optimization technology was applied to cameras equipped with Sony’s IMX500 smart image sensor, achieving a 100% accuracy in the verification process.

“ITS World Congress 2025 was a pivotal opportunity to demonstrate the global competitiveness of our generative AI-based ITS solutions, built on both domestic and international partnerships. Moving forward, we will continue to strengthen our global presence and lead the future of smart city traffic management and mobility innovation.” said Myungsu Chae, CEO of Nota AI.

Nota AI’s leadership in ITS has been validated by both technical performance and global commercialization. In Korea, the company’s ITS solution received the highest rating in the Ministry of Land, Infrastructure and Transport’s Smart Intersection System performance evaluation, achieving more than 99% accuracy. In April, Nota AI became the first Korean company to successfully commercialize generative AI-based ITS solutions in the Middle East through a supply agreement with the Dubai Roads and Transport Authority (RTA).

Nota AI plans to showcase these business achievements at the upcoming 2026 Gangneung ITS World Congress, aiming to build a successful congress and expand its global network. Additionally, the company was recently selected as a final member of the Ministry of Science and ICT’s “National AI” project, advancing the development of its proprietary foundation models. In August, Nota AI also filed its securities registration statement, with plans to complete its KOSDAQ listing by the end of the year.

BERLIN, Aug. 29, 2025 /PRNewswire/ — Morphy Richards, a trusted name in home appliances with 89 years of legacy, will unveil its latest innovations at IFA Berlin 2025 (September 5–9, Hall 7.1C, Booth 105) under the theme “Innovate for Enlightening Progress”. The showcase will highlight Morphy Richards’ fusion of heritage craftsmanship with advanced technology, redefining modern living.

Flagship Innovations for Today’s Homes

Building on the success of the S1 Pro—the world’s first ductless air conditioner, which raised about $1 million on Kickstarter and earned accolades at IFA 2024, Morphy Richards will debut the S1 Ultra at IFA 2025. Powered by Fusion Max Tech, the S1 Ultra offers five-in-one functionality, including cooling, heating, humidifying, airflow, and ductless operation, providing year-round comfort. Inspired by aircraft engines and accented with subtle wood elements, it combines advanced innovation with elegant design, reflecting its deep, user-driven insight.

Alongside the S1 Ultra, Morphy Richards will showcase upgraded Fusion Kettle and Toaster Set with ergonomic handle and wood-inspired elements that blend functionality with minimalist elegance. Morphy Richards will also debut innovations like Infusechill Flavored Ice, MixChill 3-in-1 Ice Maker, Fully Automatic Espresso Machine, and classic ranges for onsite exploration.

Global Expansion and Partnerships

IFA serves as a strategic platform for Morphy Richards to unveil flagship products and expand its global footprint. Over the past year, the brand has gained recognition from media, influencers, and athletes globally—highlighted during the Paris Olympics—cementing its reputation for smart, modern solutions.

Looking forward, Morphy Richards is focused on building strategic partnerships, investing in sustainable manufacturing, and expanding its product portfolio to make innovative appliances accessible to more households.  The upcoming IFA Berlin launches reflect the brand’s commitment to “Enlightening Progress”, seamlessly blending heritage craftsmanship with forward-thinking design to enhance everyday life while delivering reliable, technologically advanced, and aesthetically elegant solutions.

Visit Us at Hall 7.1C, Booth 105

Visitors can explore live demos, engage with experts, and discover how Morphy Richards combines heritage with futurism to create stylish, intelligent environments, as showcased by its commitment to “Innovate for Enlightening Progress”.

About Morphy Richards

Morphy Richards, founded in 1936, is a global leader in home appliances across 26 countries. With 89 years of innovation, we deliver reliable support, smart solutions, and tailored services, empowering partners and consumers with quality excellence and sustainable growth worldwide.

Discover more: morphyrichards.com

PR contact
Email: marketing@morphyrichards.com

DUBAI, UAE, Aug. 29, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has enabled volatility indices trading on Bybit Advanced Earn with the integration of the Bitcoin Volmex Implied Volatility Index (BVIV) and Ethereum Volmex Implied Volatility Index (EVIV). Starting now, Bybit users can trade on market sentiment and volatility trends of crypto’s golden pair of blue-chip assets—BTC and ETH.

The advanced volatility indices by Volmex, the leader in crypto volatility indices and other novel crypto indices, allow traders to seize opportunities based on the market volatility of BTC and ETH. Measuring implied volatility in the crypto options market, BVIV and EVIV reflects the market’s 30-day forward-looking volatility expectations of BTC and ETH derived from option prices across leading cryptocurrency exchanges. This real-time data transforms how traders can approach market timing and build volatility-based trading strategies.

Combining Bybit’s powerful trading suite and BVIV and EVIV’s institutional-grade insights, traders may formulate effective and personalized trading strategies:

• High Volatility Readings – Short Volatility Opportunities: When BVIV and EVIV show elevated levels, indicating heightened market tension and expectations of large price swings, savvy traders can implement short volatility strategies. As market risk expectations ease and volatility premiums shrink, strategies such as Dual Asset products allow traders to lock in high premiums, while Discount Buy strategies enable asset acquisition at lower effective prices.
• Low Volatility Environments – Long Volatility Setups: Conversely, when indices display lower values indicating calmer market sentiment, they signal growing expectations for future market swings. This presents opportunities for long volatility strategies including Double-Win products that generate profits from price movement in either direction, and Smart Leverage options that amplify returns when market trends become clear.

Bringing Institutional-Grade Volatility Analysis to Retail Traders
Bybit Advanced Earn is dedicated to empowering traders with advanced market intelligence and tools by bringing Volmex’s sophisticated and market-tested volatility indicators. Backed by Volmex, the indices match BVIV and EVIV to the corresponding structured products based on real-time market signals, based on TradingView and CoinMarketCap data.

The BVIV and EVIV indices represent another step forward in democratizing professional trading tools. Similar to the VIX in traditional finance and the widely-followed Crypto Fear & Greed Index, the indices provide traders with instant updates on market sentiment and volatility expectations.

Bybit users may explore the new feature on Bybit Advanced Earn to view live data, track volatility trends, and access tailored recommendations. Terms and conditions and eligibility requirements apply. Investment comes with risk and trading strategy examples are not intended as advice. Users are advised to conduct their own research.

#Bybit / #TheCryptoArk

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 70 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

• Strategic Move Positions YD Bio Limited for Accelerated Innovation and Market Expansion
• Trading of common stock and warrants of the new public company, YD Bio Limited, is expected to commence on the Nasdaq Global Market on August 29, 2025, under the ticker symbols “YDES” and “YDESW”

NEW YORK, Aug. 29, 2025 /PRNewswire/ — YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced the successful completion of its previously announced business combination with Breeze Holdings Acquisition Corp. (“Breeze”), a publicly traded special purpose acquisition company. Beginning August 29, 2025, YD Bio’s ordinary shares and warrants will trade on Nasdaq Global Market under the ticker symbols “YDES” and “YDESW,” respectively. The transaction was approved by Breeze shareholders at an extraordinary general meeting held on August 14, 2025.

The Company also announced that the previously announced PIPE offering closed, in full, contemporaneously with the closing of the business combination. The proceeds of the PIPE offering together with the cash released to the Company from the trust for the benefit of the former Breeze shareholders, after satisfaction of all business combination closing-related expenses, is expected to yield more than $11,500,000 to fund the Company’s future operations.

The Business Combination and the PIPE closing mark a significant step in the Company’s evolution, positioning YD Bio Ltd as an emerging leader in the biotech industry with strong growth potential across multiple fast-growing healthcare markets. By entering the public markets, YD Bio Ltd is poised to accelerate innovation, scale production, and drive the development and commercialization of groundbreaking technologies.

YD Bio Ltd’s business model centers on partnerships with biopharmaceutical companies to transform innovative technologies into commercially viable drugs and cancer detection diagnostics. Led by Chairman Dr. Ethan Shen, a biomedical expert with over 30 years of experience, the Company is focused on advancing a diversified portfolio of innovative healthcare solutions across oncology diagnostics, regenerative medicine, and clinical trial support. The Company’s core programs include:

• Blood-Based Cancer Detection: Through exclusive licensing agreements with its partner EG BioMed, the Company is developing proprietary DNA methylation-based detection technology for a range of cancers. This includes a screening test for the early detection of pancreatic cancer, which is available as a laboratory-developed test (LDT) through EG BioMed’s CLIA-certified laboratory, and a monitoring test for recurrent breast cancer, expected to launch as an LDT later this year.
• Stem Cell- and Exosome-Based Ophthalmology Therapies: In partnership with 3D Global Biotech, the Company is advancing corneal stem cell and exosome technologies for the treatment of ocular diseases such as dry eye syndrome, glaucoma, and corneal injury. Clinical development efforts are underway, with Institutional Review Board (IRB)-approved specimen collection and plans to initiate trials evaluating exosome-based contact lenses and artificial tears in 2027.
• Clinical Trial and Ancillary Services: The Company has served as a trusted supplier of investigational drugs and ancillary materials to global pharmaceutical companies, supporting clinical development and post-launch commercialization.

The Company’s multi-decade exclusive licensing agreements, together with its proprietary patented technologies, provide the Company with a significant first-mover advantage across its clinical markets.

“Today is an incredibly proud moment and a major milestone for our company, our employees and our shareholders, as we begin our journey as a publicly traded company,” said Dr. Ethan Shen, Chairman of the Board and Chief Executive Officer of YD Bio Ltd. “Since our founding in 2013, YD Bio has evolved from a supplier of clinical trial drugs and health supplements into a dynamic innovator in diagnostics and therapeutics. From pioneering exosome technologies to advancing early cancer detection, our progress reflects years of dedication and transformation. Becoming a publicly traded Nasdaq-listed company enables us to accelerate our mission of delivering innovative solutions that improve lives and advance global health. We are profoundly grateful to the patients who participate in our trials, our dedicated team members, and our investors. We believe this achievement represents the next step in advancing our programs and products, redefining the future of healthcare, and bringing life-changing solutions to patients who need them.”

Advisors

ArentFox Schiff LLP and Ogier acted as legal advisors to the Company. I-Bankers Securities, Inc. acted as financial advisor to Breeze. Woolery & Co. PLLC acted as legal advisor to Breeze.

About YD Bio Limited

YD Bio Limited is a biotechnology company focused on advancing clinical trials, new drug development, cancer prevention diagnostics, stem cell and exosome therapies with the potential to transform the treatment of diseases with high unmet medical need. The Company is committed to improving patient outcomes through scientific innovation and precision medicine. In addition to its R&D efforts, YD Bio Limited is a recognized supplier of clinical trial drugs and has expanded into the development and distribution of post-market auxiliary products. For more information, please visit the Company’s website: www.ydesgroup.com

About Breeze Holdings Acquisition Corp.

Breeze Holdings is a blank check company organized for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses or entities.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements, including, but not limited to, YD Bio’s business plan and outlook. These forward-looking statements involve known and unknown risks and uncertainties and are based on YD Bio’s current expectations and projections about future events that YD Bio believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions. YD Bio undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although YD Bio believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and YD Bio cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in YD Bio’s registration statement and other filings with the U.S. Securities and Exchange Commission.

For investor and media inquiries, please contact:

YD Bio Limited
Investor Relations
Email: investor@ydesgroup.com 

Jackson Lin
LLYC US
Phone: +1 (646) 717-4593
Email: jian.lin@llyc.global

PANAMA CITY, Aug. 29, 2025 /PRNewswire/ — BingX, a leading cryptocurrency exchange and Web3 AI company, today announced its participation as a Sea Sponsor at ETHWarsaw 2025, a premier Web3 conference and hackathon.

Taking place September 4–7, the event will bring together developers, researchers, founders, and innovators to collaborate on shaping the future of decentralized technologies. Now in its fourth edition, ETHWarsaw has established itself both as Poland’s most impactful Web3 gathering, and a key event across the broader Eastern European region by offering hands-on learning, technical workshops, and vibrant industry discussions.

During ETHWarsaw, BingX will host a booth showcasing its vision for AI-powered Web3 ecosystems, and how these technologies can enhance accessibility for users throughout the community. Additionally, Vivien Lin, Chief Product Officer at BingX, will serve as a judge for the hackathon and deliver a keynote speech on the transformative role of AI in Web3, as well as join a main stage panel discussion on the mass adoption of Real-World Assets (RWAs) in the industry. 

“ETHWarsaw embodies the spirit of collaboration and experimentation that drives Web3 forward,” said Lin. “By joining ETHWarsaw as a sponsor, we’re not only contributing to critical conversations but also underscoring BingX’s vision: to bridge intelligence, accessibility, and user-first innovation with AI in the digital asset economy. Our presence at ETHWarsaw reflects our commitment to fostering the builders and ideas that will shape the next era of Web3.”

Looking ahead, BingX remains focused on empowering traders and developers alike with AI-driven solutions, transparent trading infrastructure, and collaborative engagement across global Web3 communities. Participation in ETHWarsaw 2025 reinforces BingX’s role as both a leading exchange and a key partner in advancing the adoption of decentralized finance and AI-powered innovation worldwide.

About BingX
Founded in 2018, BingX is a leading crypto exchange and Web3 AI company, serving a global community of over 20 million users. With a comprehensive suite of AI-powered products and services, including derivatives, spot trading, and copy trading, BingX caters to the evolving needs of users across all experience levels, from beginners to professionals. Committed to building a trustworthy and intelligent trading platform, BingX empowers users with innovative tools designed to enhance performance and confidence. In 2024, BingX proudly became the official crypto exchange partner of Chelsea Football Club, marking an exciting debut in the world of sports sponsorship.

For more information please visit: https://bingx.com/